Jun 11, 2026 07:30AM
Jun 11, 2026 07:30AM
Jun 4, 2026 04:02PM
May 30, 2026 08:00AM
May 30, 2026 08:00AM
May 27, 2026 08:00AM
May 12, 2026 04:02PM Immunome Reports First Quarter 2026 Financial Results and Provides Business Update
Apr 29, 2026 07:30AM
Apr 29, 2026 07:30AM
Apr 21, 2026 10:30AM
Apr 21, 2026 10:30AM
Mar 3, 2026 04:02PM
Feb 5, 2026 09:26AM
Dec 16, 2025 12:18PM Cancer Drug Developers Secure Regulatory Clarity as FDA Reshapes Approval Standards
Dec 16, 2025 07:20AM
Dec 15, 2025 07:00AM
Dec 15, 2025 07:00AM
Nov 17, 2025 07:08AM
Aug 6, 2025 04:05PM
Feb 11, 2025 08:30AM
Jan 13, 2025 08:00AM Immunome Provides Pipeline Update in Advance of Presentation at the 43rd Annual J.P. Morgan Healthcare Conference
Oct 29, 2024 08:00AM
Oct 18, 2024 08:00AM
Jul 25, 2024 08:00AM
Mar 26, 2024 08:00AM
Feb 20, 2024 08:00AM
Feb 6, 2024 08:00AM
Feb 6, 2024 08:00AM Immunome To Acquire AL102, A Phase 3 Asset for the Treatment of Desmoid Tumors, From Ayala Pharmaceuticals
Nov 9, 2023 08:00AM
Oct 3, 2023 08:05AM
Oct 3, 2023 08:00AM
Jun 29, 2023 09:01AM
Jun 29, 2023 09:00AM
May 23, 2023 04:07PM
May 23, 2023 04:05PM Immunome Publishes Preclinical Research Demonstrating that Inhibition of IL-38 Using an Antibody Leads to Anti-Tumor Activity
May 5, 2023 08:00AM
Mar 16, 2023 08:00AM
Mar 9, 2023 08:45AM
Feb 8, 2023 08:00AM
Jan 6, 2023 08:02AM
Jan 6, 2023 08:00AM
Jan 6, 2023 08:00AM AbbVie and Immunome Announce Strategic Collaboration to Discover Multiple Novel Oncology Targets
Nov 14, 2022 08:00AM
Nov 9, 2022 12:04PM
Nov 9, 2022 12:00PM
Nov 7, 2022 08:17AM
Nov 7, 2022 08:15AM
Aug 23, 2022 09:00AM
Aug 5, 2022 08:00AM Immunome Reports Second Quarter 2022 Financial Results
Jul 6, 2022 08:02AM

323,580 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All